Methods |
Randomised trial with concurrent eligible patients outside of the RCT. The non‐RCT patients consisted of 97 patients who refused randomizations and 353 patients whose physician did not agree, all non‐RCT patients were followed in a registry. Patients with 2‐ or 3‐vessels coronary artery disease, both sexes. Outcomes were assessed by cardiologists. No losses to follow up. |
Data |
Characteristics of non‐RCT patients presented and compared to RCT patients who received the same treatment. Bypass treated RCT patients were mean 61 (10) years, 53 women and 141 men. Bypass treated non‐RCT patients were mean 63 (10) years, 51 women and 219 men. |
Comparisons |
Two RCT arms, each of them were compared with similarly treated eligible non‐RCT patients. Carotid bypass surgery. Percutaneous transluminal coronary angioplasty. |
Outcomes |
Clinical outcomes were assessed in all the patients. Patients were followed for 3 years. Main outcome was 3 years mortality. |
Notes |
The two RCT treatments were not statistically different. |